Cardiff Oncology Files 8-K on Security Holder Vote
Ticker: CRDF · Form: 8-K · Filed: Jun 26, 2025 · CIK: 1213037
| Field | Detail |
|---|---|
| Company | Cardiff Oncology, Inc. (CRDF) |
| Form Type | 8-K |
| Filed Date | Jun 26, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: CRDF
TL;DR
Cardiff Oncology (CRDF) filed an 8-K for a security holder vote - details TBD.
AI Summary
On June 26, 2025, Cardiff Oncology, Inc. filed an 8-K report detailing a submission of matters to a vote of security holders. The filing does not contain specific details about the matters to be voted on or any associated financial figures.
Why It Matters
This filing indicates that Cardiff Oncology is seeking approval from its security holders on certain matters, which could impact corporate governance or strategic decisions.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose any immediate financial or operational risks.
Key Players & Entities
- Cardiff Oncology, Inc. (company) — Registrant
- June 26, 2025 (date) — Date of earliest event reported
FAQ
What specific matters are being submitted for a vote by Cardiff Oncology's security holders?
The provided 8-K filing states that it is a 'Submission of Matters to a Vote of Security Holders' but does not specify the exact matters.
When was this 8-K filing submitted?
The filing was submitted on June 26, 2025.
What is Cardiff Oncology's principal executive office address?
Cardiff Oncology's principal executive offices are located at 11055 Flintkote Avenue, San Diego, CA 92121.
What is Cardiff Oncology's IRS Employer Identification Number (EIN)?
Cardiff Oncology's EIN is 27-2004382.
Has Cardiff Oncology changed its name previously?
Yes, Cardiff Oncology, Inc. was formerly known as Trovagene, Inc. (name change on March 4, 2013), and prior to that, TrovaGene Inc. (name change on August 30, 2011), and XENOMICS INC (name change on July 19, 2004).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 26, 2025 regarding Cardiff Oncology, Inc. (CRDF).